1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Holliger, P. Riechmann, L. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK Structure STRUE6 2005 0969-2126 5 265 275 10.1016/S0969-2126(97)00184-6 9032075 A conserved infection pathway for filamentous bacteriophages is suggested by the structure of the membrane penetration domain of the minor coat protein g3p from phage fd. 1997 10.2210/pdb1fgp/pdb pdb_00001fgp 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 7711.479 FD GENE 3 PROTEIN DOMAIN 1 1 man polymer no no ETVESCLAKPHTENSFTNVWKDDKTLDRYANYEGCLWNATGVVVCTGDETQCYGTWVPIGLAIPENAAAH ETVESCLAKPHTENSFTNVWKDDKTLDRYANYEGCLWNATGVVVCTGDETQCYGTWVPIGLAIPENAAAH A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Inovirus Enterobacteria phage M13 Escherichia sample 10864 Enterobacteria phage fd SUPERNATANT 562 Escherichia coli PUC119 database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1997-06-16 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1996-12-10 REL REL LOWEST TOTAL ENERGIES 50 15 15N + 13C NOESY-HMQC 6.2 303 K SEE JRNL REFERENCE. simulated annealing BRUNGER refinement X-PLOR structure solution X-PLOR 500 Bruker AMX500 GLU 1 n 1 GLU 1 A THR 2 n 2 THR 2 A VAL 3 n 3 VAL 3 A GLU 4 n 4 GLU 4 A SER 5 n 5 SER 5 A CYS 6 n 6 CYS 6 A LEU 7 n 7 LEU 7 A ALA 8 n 8 ALA 8 A LYS 9 n 9 LYS 9 A PRO 10 n 10 PRO 10 A HIS 11 n 11 HIS 11 A THR 12 n 12 THR 12 A GLU 13 n 13 GLU 13 A ASN 14 n 14 ASN 14 A SER 15 n 15 SER 15 A PHE 16 n 16 PHE 16 A THR 17 n 17 THR 17 A ASN 18 n 18 ASN 18 A VAL 19 n 19 VAL 19 A TRP 20 n 20 TRP 20 A LYS 21 n 21 LYS 21 A ASP 22 n 22 ASP 22 A ASP 23 n 23 ASP 23 A LYS 24 n 24 LYS 24 A THR 25 n 25 THR 25 A LEU 26 n 26 LEU 26 A ASP 27 n 27 ASP 27 A ARG 28 n 28 ARG 28 A TYR 29 n 29 TYR 29 A ALA 30 n 30 ALA 30 A ASN 31 n 31 ASN 31 A TYR 32 n 32 TYR 32 A GLU 33 n 33 GLU 33 A GLY 34 n 34 GLY 34 A CYS 35 n 35 CYS 35 A LEU 36 n 36 LEU 36 A TRP 37 n 37 TRP 37 A ASN 38 n 38 ASN 38 A ALA 39 n 39 ALA 39 A THR 40 n 40 THR 40 A GLY 41 n 41 GLY 41 A VAL 42 n 42 VAL 42 A VAL 43 n 43 VAL 43 A VAL 44 n 44 VAL 44 A CYS 45 n 45 CYS 45 A THR 46 n 46 THR 46 A GLY 47 n 47 GLY 47 A ASP 48 n 48 ASP 48 A GLU 49 n 49 GLU 49 A THR 50 n 50 THR 50 A GLN 51 n 51 GLN 51 A CYS 52 n 52 CYS 52 A TYR 53 n 53 TYR 53 A GLY 54 n 54 GLY 54 A THR 55 n 55 THR 55 A TRP 56 n 56 TRP 56 A VAL 57 n 57 VAL 57 A PRO 58 n 58 PRO 58 A ILE 59 n 59 ILE 59 A GLY 60 n 60 GLY 60 A LEU 61 n 61 LEU 61 A ALA 62 n 62 ALA 62 A ILE 63 n 63 ILE 63 A PRO 64 n 64 PRO 64 A GLU 65 n 65 GLU 65 A ASN 66 n 66 ASN 66 A ALA 67 n 67 ALA 67 A ALA 68 n 68 ALA 68 A ALA 69 n 69 ALA 69 A HIS 70 n 70 HIS 70 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O THR 12 A O THR 12 A N TRP 56 A N TRP 56 A O GLN 51 A O GLN 51 A N THR 46 A N THR 46 A O TRP 20 A O TRP 20 A N TYR 29 A N TYR 29 A O ARG 28 A O ARG 28 A N ALA 39 A N ALA 39 A O LEU 36 A O LEU 36 A N GLY 60 A N GLY 60 1 A ARG 28 0.311 SIDE CHAIN 2 A ARG 28 0.218 SIDE CHAIN 3 A ARG 28 0.293 SIDE CHAIN 4 A ARG 28 0.308 SIDE CHAIN 5 A ARG 28 0.178 SIDE CHAIN 6 A ARG 28 0.308 SIDE CHAIN 7 A ARG 28 0.141 SIDE CHAIN 8 A ARG 28 0.175 SIDE CHAIN 9 A ARG 28 0.227 SIDE CHAIN 10 A ARG 28 0.234 SIDE CHAIN 11 A ARG 28 0.314 SIDE CHAIN 12 A ARG 28 0.197 SIDE CHAIN 13 A ARG 28 0.285 SIDE CHAIN 14 A ARG 28 0.136 SIDE CHAIN 15 A ARG 28 0.124 SIDE CHAIN 1 A LYS 9 -46.66 179.90 1 A HIS 11 69.17 81.40 1 A THR 12 86.00 -59.34 1 A GLU 13 -44.84 97.08 1 A ASN 14 168.53 -149.52 1 A SER 15 178.83 -173.12 1 A VAL 19 -46.96 156.42 1 A LEU 26 70.90 58.97 1 A ASP 27 170.94 176.77 1 A GLU 33 35.42 95.59 1 A THR 40 -101.77 -91.53 1 A VAL 42 -50.96 89.14 1 A ILE 59 -154.95 -32.49 1 A ALA 62 173.11 43.89 1 A ILE 63 163.15 -36.26 1 A GLU 65 -72.20 -156.61 1 A ALA 68 75.62 47.49 2 A THR 2 67.44 124.56 2 A LYS 9 -46.92 -179.76 2 A HIS 11 71.60 81.24 2 A THR 12 86.14 -59.53 2 A GLU 13 -44.88 98.94 2 A ASN 14 167.44 -158.02 2 A ASN 18 58.32 18.84 2 A VAL 19 -41.94 153.70 2 A LEU 26 71.08 62.02 2 A ASP 27 167.37 170.89 2 A GLU 33 34.67 93.02 2 A THR 40 -86.12 -150.43 2 A GLU 49 81.73 28.18 2 A ILE 59 -159.34 -32.85 2 A ALA 62 171.45 52.59 2 A ILE 63 158.39 -41.55 2 A GLU 65 -82.64 -154.19 2 A ASN 66 -91.54 49.89 2 A ALA 67 179.26 110.30 2 A ALA 68 -43.25 99.45 3 A THR 2 57.28 98.41 3 A LYS 9 -46.01 -178.64 3 A HIS 11 71.68 81.89 3 A THR 12 84.89 -59.53 3 A GLU 13 -44.86 98.95 3 A ASN 14 165.44 -154.84 3 A SER 15 -178.65 -170.06 3 A VAL 19 -48.34 151.21 3 A LEU 26 70.50 59.28 3 A ASP 27 168.54 174.72 3 A GLU 33 35.54 88.78 3 A VAL 43 -116.01 -167.75 3 A ILE 59 -150.20 -29.79 3 A ALA 62 173.32 47.79 3 A ILE 63 161.78 -38.70 3 A GLU 65 -61.12 -154.76 3 A ALA 67 -163.57 -166.96 3 A ALA 68 58.44 -89.02 4 A LYS 9 -45.45 179.36 4 A HIS 11 72.73 81.70 4 A THR 12 86.28 -58.24 4 A GLU 13 -44.96 99.02 4 A ASN 14 165.18 -155.55 4 A SER 15 -177.20 -171.21 4 A PHE 16 -176.98 148.45 4 A VAL 19 -38.94 153.28 4 A ASP 27 168.16 164.23 4 A ASN 31 -67.86 96.33 4 A GLU 33 29.50 81.08 4 A VAL 42 -63.16 89.33 4 A VAL 44 -51.18 103.23 4 A GLU 49 80.29 27.85 4 A ILE 59 -145.62 -28.30 4 A ALA 62 171.31 51.37 4 A ILE 63 159.23 -39.73 4 A GLU 65 -76.84 -146.73 4 A ALA 68 -96.65 -151.17 4 A ALA 69 63.10 100.69 5 A THR 2 62.86 103.81 5 A LYS 9 -44.79 -178.19 5 A HIS 11 73.65 163.43 5 A THR 12 -12.54 -53.67 5 A GLU 13 -43.17 97.28 5 A ASN 14 169.31 -156.92 5 A SER 15 -174.77 -168.18 5 A PHE 16 178.23 146.61 5 A VAL 19 -41.31 163.48 5 A LEU 26 71.60 67.43 5 A ASP 27 167.01 167.45 5 A GLU 33 27.36 81.60 5 A THR 40 -143.44 -48.48 5 A VAL 44 -62.10 97.02 5 A GLU 49 74.82 -2.05 5 A ILE 59 -144.64 -34.32 5 A ALA 62 171.70 40.13 5 A ILE 63 162.18 -36.72 5 A GLU 65 -78.97 -156.93 6 A THR 2 44.62 96.10 6 A ALA 8 -52.04 -72.00 6 A LYS 9 41.66 -173.67 6 A HIS 11 71.99 164.18 6 A THR 12 -13.68 -52.00 6 A GLU 13 -45.10 98.13 6 A ASN 14 168.51 -153.28 6 A SER 15 -179.80 -167.23 6 A PHE 16 -179.38 141.03 6 A VAL 19 -39.26 163.15 6 A LEU 26 65.99 68.89 6 A ASP 27 164.27 162.11 6 A GLU 33 -66.41 88.22 6 A THR 40 -77.85 -154.80 6 A VAL 42 -105.95 79.65 6 A ALA 62 -155.09 -68.74 6 A GLU 65 -81.93 -158.38 6 A ALA 68 49.78 70.91 7 A THR 2 71.87 131.19 7 A LYS 9 -46.51 -178.61 7 A HIS 11 71.36 167.39 7 A THR 12 -15.46 -52.80 7 A GLU 13 -44.74 98.24 7 A ASN 14 167.48 -150.78 7 A SER 15 177.57 -169.64 7 A VAL 19 -40.04 154.53 7 A LEU 26 65.20 64.61 7 A ASP 27 170.84 162.93 7 A GLU 33 38.40 34.27 7 A THR 40 -60.47 -133.62 7 A ILE 59 -150.88 -34.24 7 A ALA 62 167.18 53.55 7 A ILE 63 161.93 -41.83 7 A GLU 65 -70.84 -148.50 7 A ALA 67 173.66 36.37 7 A ALA 68 -143.30 20.00 8 A LYS 9 -48.02 -178.70 8 A HIS 11 71.05 82.03 8 A THR 12 88.15 -59.25 8 A GLU 13 -42.77 98.11 8 A ASN 14 167.84 -154.72 8 A SER 15 179.37 -173.10 8 A LEU 26 72.99 59.06 8 A ASP 27 168.52 169.56 8 A GLU 33 30.15 77.75 8 A THR 40 -139.33 -42.10 8 A ILE 59 -149.34 -32.18 8 A ALA 62 168.61 42.42 8 A ILE 63 164.58 -36.75 8 A GLU 65 -75.35 -163.44 9 A LYS 9 -46.30 -177.97 9 A HIS 11 73.31 167.56 9 A THR 12 -11.40 -54.27 9 A GLU 13 -43.45 97.35 9 A ASN 14 169.83 -152.09 9 A SER 15 -179.17 -171.81 9 A PHE 16 -173.92 149.07 9 A VAL 19 -41.75 154.59 9 A LEU 26 71.61 57.35 9 A ASP 27 168.15 175.74 9 A GLU 33 39.33 43.64 9 A THR 40 -141.25 -41.47 9 A VAL 44 -56.98 94.04 9 A ALA 62 172.68 50.76 9 A ILE 63 158.84 -40.99 9 A GLU 65 -81.30 -156.68 9 A ASN 66 -94.96 36.35 9 A ALA 67 -161.11 -61.12 9 A ALA 68 175.63 142.45 9 A ALA 69 -95.47 -146.06 10 A THR 2 52.87 91.77 10 A LYS 9 -46.82 -174.59 10 A HIS 11 72.07 164.44 10 A THR 12 -11.65 -54.27 10 A GLU 13 -45.06 97.19 10 A ASN 14 170.78 -153.46 10 A SER 15 179.27 174.29 10 A VAL 19 -41.08 154.96 10 A LEU 26 76.24 69.64 10 A ASP 27 169.04 161.42 10 A TYR 32 -97.60 52.75 10 A GLU 33 30.93 96.38 10 A THR 40 -134.82 -68.26 10 A VAL 44 -52.81 106.28 10 A ALA 62 173.66 49.42 10 A ILE 63 163.36 -47.71 10 A GLU 65 -137.15 -79.94 10 A ALA 69 50.58 89.11 11 A LYS 9 -47.80 -176.77 11 A HIS 11 69.82 81.07 11 A THR 12 85.60 -57.63 11 A GLU 13 -44.77 98.29 11 A ASN 14 165.07 -153.68 11 A SER 15 177.36 -167.10 11 A PHE 16 -179.83 139.33 11 A VAL 19 -47.14 167.25 11 A LEU 26 64.40 72.08 11 A ASP 27 162.78 171.34 11 A THR 40 -63.93 -85.52 11 A ALA 62 -143.96 -62.13 11 A GLU 65 -73.93 -167.56 11 A ASN 66 -97.77 35.00 11 A ALA 68 52.92 -90.80 11 A ALA 69 -60.91 89.04 12 A THR 2 74.61 139.01 12 A LYS 9 -45.84 178.79 12 A HIS 11 71.30 166.25 12 A THR 12 -14.04 -53.05 12 A GLU 13 -42.51 98.56 12 A ASN 14 162.99 -156.00 12 A SER 15 -175.76 -166.97 12 A PHE 16 179.65 156.80 12 A ASN 18 58.64 17.82 12 A VAL 19 -45.70 157.40 12 A LEU 26 80.89 64.57 12 A ASP 27 166.29 174.54 12 A TYR 32 -92.89 50.35 12 A GLU 33 33.56 94.31 12 A VAL 42 -60.48 87.76 12 A GLU 49 79.65 -3.70 12 A ILE 59 -154.28 -32.55 12 A ALA 62 172.76 44.94 12 A ILE 63 164.66 -32.89 12 A GLU 65 -68.08 -143.01 12 A ALA 67 163.48 53.52 12 A ALA 68 -128.43 -93.02 13 A LYS 9 -45.07 177.44 13 A HIS 11 72.85 81.11 13 A THR 12 83.91 -58.84 13 A GLU 13 -46.12 97.13 13 A ASN 14 167.96 -148.69 13 A SER 15 179.27 -169.93 13 A PHE 16 179.92 148.82 13 A VAL 19 -49.17 151.49 13 A LEU 26 82.10 60.92 13 A ASP 27 160.33 170.72 13 A GLU 33 34.01 82.84 13 A THR 40 -135.97 -50.66 13 A VAL 44 -48.75 101.25 13 A GLU 49 76.58 -4.89 13 A ILE 59 -142.23 -34.21 13 A ALA 62 171.06 52.83 13 A ILE 63 149.84 -32.53 13 A GLU 65 -125.03 -169.83 13 A ALA 67 -49.88 -71.98 13 A ALA 68 74.63 107.57 13 A ALA 69 47.33 96.48 14 A LYS 9 -54.76 -171.76 14 A HIS 11 72.19 169.48 14 A THR 12 -15.58 -53.73 14 A GLU 13 -44.95 98.01 14 A ASN 14 169.75 -147.29 14 A SER 15 176.65 -172.42 14 A PHE 16 -174.09 143.28 14 A VAL 19 -39.27 161.28 14 A LEU 26 72.97 62.97 14 A ASP 27 165.37 167.94 14 A ASN 31 -69.18 93.82 14 A GLU 33 30.74 98.09 14 A THR 40 -143.68 -58.51 14 A ASP 48 59.75 16.10 14 A ALA 62 -157.77 -60.96 14 A GLU 65 -77.81 -149.82 15 A THR 2 65.66 96.14 15 A LYS 9 -45.79 179.11 15 A HIS 11 -31.32 89.31 15 A THR 12 85.65 -58.56 15 A GLU 13 -46.99 97.87 15 A ASN 14 165.32 -151.05 15 A SER 15 -179.48 -172.49 15 A ASN 18 56.43 19.05 15 A VAL 19 -48.58 161.79 15 A LEU 26 73.15 66.12 15 A ASP 27 160.89 173.76 15 A TYR 32 -111.71 54.24 15 A GLU 33 28.36 97.36 15 A VAL 42 -66.00 88.60 15 A VAL 44 -54.45 106.14 15 A ALA 62 -172.76 107.94 15 A PRO 64 -85.53 -84.36 15 A GLU 65 152.44 53.80 15 A ASN 66 79.94 -73.24 15 A ALA 69 -131.30 -83.30 model building X-PLOR refinement X-PLOR phasing X-PLOR MEMBRANE PENETRATION DOMAIN OF THE MINOR COAT PROTEIN G3P OF PHAGE FD, NMR, 15 STRUCTURES 1 Y N A VAL 3 A VAL 3 HELX_P A ALA 8 A ALA 8 1 1 6 disulf 2.020 A CYS 6 A SG CYS 6 1_555 A CYS 35 A SG CYS 35 1_555 disulf 2.023 A CYS 45 A SG CYS 45 1_555 A CYS 52 A SG CYS 52 1_555 VIRAL PROTEIN PHAGE COAT PROTEIN, SH3 DOMAIN, PH DOMAIN, PDZ DOMAIN, FD PHAGE, FILAMENTOUS PAHGE, PHAGE INFECTION, PTB DOMAIN, Viral protein COATA_BPFD UNP 1 1 P03661 MKKLLFAIPLVVPFYSHSAETVESCLAKPHTENSFTNVWKDDKTLDRYANYEGCLWNATGVVVCTGDETQCYGTWVPIGL AIPENEGGGSEGGGSEGGGSEGGGTKPPEYGDTPIPGYTYINPLDGTYPPGTEQNPANPNPSLEESQPLNTFMFQNNRFR NRQGALTVYTGTVTQGTDPVKTYYQYTPVSSKAMYDAYWNGKFRDCAFHSGFNEDPFVCEYQGQSSDLPQPPVNAGGGSG GGSGGGSEGGGSEGGGSEGGGSEGGGSGGGSGSGDFDYEKMANANKGAMTENADENALQSDAKGKLDSVATDYGAAIDGF IGDVSGLANGNGATGDFAGSNSQMAQVGDGDNSPLMNNFRQYLPSLPQSVECRPYVFGAGKPYEFSIDCDKINLFRGVFA FLLYVATFMYVFSTFANILRNKES 20 85 1FGP 1 66 P03661 A 1 1 66 3 4 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A THR 12 A THR 12 A PHE 16 A PHE 16 A GLN 51 A GLN 51 A TRP 56 A TRP 56 A VAL 43 A VAL 43 A THR 46 A THR 46 A TRP 20 A TRP 20 A ASP 22 A ASP 22 A ASP 27 A ASP 27 A TYR 32 A TYR 32 A CYS 35 A CYS 35 A ALA 39 A ALA 39 A TRP 56 A TRP 56 A GLY 60 A GLY 60 1 P 1